{"product_id":"global-artificial-intelligence-in-medicine-market-insights-forecast-to-2028","title":"Global Artificial Intelligence in Medicine Market Insights, Forecast to 2028","description":"\u003cp\u003eGlobal Artificial Intelligence in Medicine Market Insights, Forecast to 2028\u003c\/p\u003e\n\n\u003cp\u003eMarket Analysis and Insights: Global Artificial Intelligence in Medicine Market\u003c\/p\u003e\n\n\u003cp\u003eDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Artificial Intelligence in Medicine estimated at US$ 15,103.1 million in the year 2022, is projected to reach a revised size of US$ 99,638.1 million by 2028, growing at a CAGR of 36.95% during the forecast period 2022-2028.\u003c\/p\u003e\n\n\u003cp\u003eThe USA market for Artificial Intelligence in Medicine is estimated to increase from US$ 4,236.3 million in 2022 to reach US$ 30,723.7 million by 2028, at a CAGR of 33.07% during the forecast period of 2022 through 2028.\u003c\/p\u003e\n\n\u003cp\u003eThe China market for Artificial Intelligence in Medicine is estimated to increase from US$ 1,027.7 million in 2022 to reach US$ 18,664.3 million by 2028, at a CAGR of 52.32% during the forecast period of 2022 through 2028.\u003c\/p\u003e\n\n\u003cp\u003eThe Europe market for Artificial Intelligence in Medicine is estimated to increase from US$ 4,999.1 million in 2022 to reach US$ 30,659.6 million by 2028, at a CAGR of 35.29% during the forecast period of 2022 through 2028.\u003c\/p\u003e\n\n\u003cp\u003eThe global key companies of Artificial Intelligence in Medicine include IBM, NVIDIA, Microsoft, AWS, Intel Corporation, GE Healthcare, Siemens Healthineers, Medtronic, and Atomwise, etc. In 2021, the global top five players had a share approximately 26.44% in terms of revenue.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes\u003c\/p\u003e\n\n\u003cp\u003eThis report presents an overview of global market for Artificial Intelligence in Medicine market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.\u003c\/p\u003e\n\n\u003cp\u003eThis report researches the key producers of Artificial Intelligence in Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Medicine, and key regions\/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.\u003c\/p\u003e\n\n\u003cp\u003eThis report focuses on the Artificial Intelligence in Medicinerevenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Artificial Intelligence in Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.\u003c\/p\u003e\n\n\u003cp\u003eThis report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Artificial Intelligence in Medicine revenue, projected growth trends, production technology, application and end-user industry.\u003c\/p\u003e\n\n\u003cp\u003eDescriptive company profiles of the major global players, including IBM, NVIDIA, Microsoft, AWS, Intel Corporation, GE Healthcare, Siemens Healthineers, Medtronic, and Atomwise, etc.\u003c\/p\u003e\n\n\u003cp\u003eBy Company\u003c\/p\u003e\n\n\u003cp\u003eNVIDIA\u003c\/p\u003e\n\n\u003cp\u003eIntel\u003c\/p\u003e\n\n\u003cp\u003eIBM\u003c\/p\u003e\n\n\u003cp\u003eGoogle Health\u003c\/p\u003e\n\n\u003cp\u003eMicrosoft\u003c\/p\u003e\n\n\u003cp\u003eAWS\u003c\/p\u003e\n\n\u003cp\u003eGE Healthcare\u003c\/p\u003e\n\n\u003cp\u003eSiemens Healthineers\u003c\/p\u003e\n\n\u003cp\u003eMedtronic\u003c\/p\u003e\n\n\u003cp\u003eAtomwise\u003c\/p\u003e\n\n\u003cp\u003eZebra Medical Vision\u003c\/p\u003e\n\n\u003cp\u003eCyrcadia Health\u003c\/p\u003e\n\n\u003cp\u003eAiCure\u003c\/p\u003e\n\n\u003cp\u003eAlibaba\u003c\/p\u003e\n\n\u003cp\u003eBPGbio\u003c\/p\u003e\n\n\u003cp\u003eMedasense Biometrics\u003c\/p\u003e\n\n\u003cp\u003eHindsait\u003c\/p\u003e\n\n\u003cp\u003eDell\u003c\/p\u003e\n\n\u003cp\u003eSAP\u003c\/p\u003e\n\n\u003cp\u003eSegment by Type\u003c\/p\u003e\n\n\u003cp\u003eHardware\u003c\/p\u003e\n\n\u003cp\u003eSoftware\u003c\/p\u003e\n\n\u003cp\u003eServices\u003c\/p\u003e\n\n\u003cp\u003eSegment by Application\u003c\/p\u003e\n\n\u003cp\u003eAuxiliary Diagnosis\u003c\/p\u003e\n\n\u003cp\u003eDrug Discovery\u003c\/p\u003e\n\n\u003cp\u003eHealth Management\u003c\/p\u003e\n\n\u003cp\u003eHospital Management\u003c\/p\u003e\n\n\u003cp\u003eOthers\u003c\/p\u003e\n\n\u003cp\u003eBy Region\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eUnited States\u003c\/p\u003e\n\n\u003cp\u003eCanada\u003c\/p\u003e\n\n\u003cp\u003eAsia-Pacific\u003c\/p\u003e\n\n\u003cp\u003eChina\u003c\/p\u003e\n\n\u003cp\u003eJapan\u003c\/p\u003e\n\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\n\u003cp\u003eIndia\u003c\/p\u003e\n\n\u003cp\u003eAustralia\u003c\/p\u003e\n\n\u003cp\u003eSoutheast Asia\u003c\/p\u003e\n\n\u003cp\u003eRest of Asia\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eGermany\u003c\/p\u003e\n\n\u003cp\u003eFrance\u003c\/p\u003e\n\n\u003cp\u003eU.K.\u003c\/p\u003e\n\n\u003cp\u003eItaly\u003c\/p\u003e\n\n\u003cp\u003eRussia\u003c\/p\u003e\n\n\u003cp\u003eNordic Countries\u003c\/p\u003e\n\n\u003cp\u003eRest of Europe\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eMexico\u003c\/p\u003e\n\n\u003cp\u003eBrazil\u003c\/p\u003e\n\n\u003cp\u003eRest of Latin America\u003c\/p\u003e\n\n\u003cp\u003eMiddle East \u0026amp; Africa\u003c\/p\u003e\n\n\u003cp\u003eMiddle East\u003c\/p\u003e\n\n\u003cp\u003eAfrica\u003c\/p\u003e\n\n\u003cp\u003eChapter Outline\u003c\/p\u003e\n\n\u003cp\u003eChapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.\u003c\/p\u003e\n\n\u003cp\u003eChapter 2: Revenue of Artificial Intelligence in Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.\u003c\/p\u003e\n\n\u003cp\u003eChapter 3: Detailed analysis of Artificial Intelligence in Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.\u003c\/p\u003e\n\n\u003cp\u003eChapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.\u003c\/p\u003e\n\n\u003cp\u003eChapter 6: North America by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 7: Europe by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 9: Latin America by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 10: Middle East and Africa by Type, by Application and by country, revenue for each segment.\u003c\/p\u003e\n\n\u003cp\u003eChapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Medicinerevenue, gross margin, and recent development, etc.\u003c\/p\u003e\n\n\u003cp\u003eChapter 12: Analyst's Viewpoints\/Conclusions\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 167 Pages \/ MCW16227190","offer_id":47645916528946,"sku":null,"price":5880.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-artificial-intelligence-in-medicine-market-insights-forecast-to-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}